Liquid Biopsy Market Report 2026
Liquid Biopsy Market Global Report 2026 Market Report Infographic Image
Item added to cart!

Published : January 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF
Purchase This Report

Liquid Biopsy Market Report 2026

Global Outlook – By Product (Assay Kits, Instruments, Services ), By Clinical Application (Early Cancer Screening, Therapy Selection, Treatment Monitoring, Recurrence Monitoring), By End User (Reference Laboratories, Hospitals and Physician Laboratories, Academic and Research Centers ) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Liquid Biopsy Market Overview

• Liquid Biopsy market size has reached to $1.46 billion in 2025

• Expected to grow to $3.11 billion in 2030 at a compound annual growth rate (CAGR) of 16.2%

• Growth Driver: Government Funding Driving Growth In The Market For Cancer Detection

• Market Trend: Advancements In Noninvasive Genomic Profiling For Solid Tumors Using Ctdna Assays

North America was the largest region in 2025 and Western Europe is the fastest growing region.

What Is Covered Under Liquid Biopsy Market?

A liquid biopsy is a quick and painless substitute for surgical biopsies that allows medical professionals to learn a lot about a tumor from a small blood sample. A liquid biopsy is a diagnostic test performed on blood to detect the presence of any cancerous cells in the blood. It is used to detect cancer at an early stage.

The main product types of liquid biopsy are assay kits, instruments, and services. Assay kits provide the reagents needed to conduct analytical tests for the measurement of specific analysis in industries such as food, cereals and dietary fiber, dairy, analytical laboratories, animal feed and nutrition, biofuels, biotechnology, wine, malting and brewing, and research. The various clinical applications include early cancer screening, therapy selection, treatment monitoring, and recurrence monitoring orthopedics that are used by reference laboratories, hospitals and physician laboratories, and academic and research centers.

Liquid Biopsy Market Global Report 2026 Market Report bar graph

What Is The Liquid Biopsy Market Size and Share 2026?

The liquid biopsy market size has grown rapidly in recent years. It will grow from $1.46 billion in 2025 to $1.71 billion in 2026 at a compound annual growth rate (CAGR) of 17.3%. The growth in the historic period can be attributed to limitations of traditional tissue biopsy procedures, increasing global cancer incidence, early adoption of blood-based diagnostics, advancements in molecular biology techniques, growing focus on early cancer diagnosis.

What Is The Liquid Biopsy Market Growth Forecast?

The liquid biopsy market size is expected to see rapid growth in the next few years. It will grow to $3.11 billion in 2030 at a compound annual growth rate (CAGR) of 16.2%. The growth in the forecast period can be attributed to rising demand for precision oncology, increasing adoption in routine cancer screening, expanding applications in recurrence monitoring, growth in oncology diagnostic spending, increasing awareness among clinicians and patients. Major trends in the forecast period include rising adoption of non-invasive cancer diagnostics, increasing use of liquid biopsy for early cancer detection, growing demand for real-time treatment monitoring, expansion of liquid biopsy in personalized oncology, rising clinical acceptance as an alternative to tissue biopsy.

Customer representative image Book your 30 minutes free consultation with our research experts

Global Liquid Biopsy Market Segmentation

1) By Product: Assay Kits, Instruments, Services

2) By Clinical Application: Early Cancer Screening, Therapy Selection, Treatment Monitoring, Recurrence Monitoring

3) By End User: Reference Laboratories, Hospitals and Physician Laboratories, Academic and Research Centers

Subsegments:

1) By Assay Kits: cfDNA Assays, ctDNA Assays, Exosome-based Assays, RNA-based Assays

2) By Instruments: PCR Instruments, Next-Generation Sequencing (NGS) Instruments, Microarray Instruments

3) By Services: Testing Services, Data Analysis Services, Laboratory Services

What Is The Driver Of The Liquid Biopsy Market?

Increase in government funding for the advancement of cancer detection is a key driver in the growth of the liquid biopsy market. Government funding for the advancement of cancer detection is primarily attributed to the rising global burden of cancer, the need for early diagnosis to improve treatment outcomes, and the focus on reducing healthcare costs through innovative diagnostic technologies. Government funding helps liquid biopsy by accelerating research and development, supporting clinical trials, and promoting the adoption of advanced, non-invasive diagnostic technologies to improve early cancer detection and personalized treatment strategies. For instance, in October 2024, gov.UK, a UK-based government website, a total of £118 ($150.38) million has been allocated to UK Research and Innovation, with £54 million from the government and £64 ($81.55) million from partners. Thus, increase in government funding for the advancement of cancer detection is driving the growth of the liquid biopsy industry.

Key Players In The Global Liquid Biopsy Market

Major companies operating in the liquid biopsy market are QIAGEN NV, Roche Diagnostics Ltd., Bio-Rad Laboratories Inc., Myriad Genetics Inc., Guardant Health Inc., Thermo Fisher Scientific Inc., Biocept Inc., Trovagene Inc., Fraunhofer-Gesellschaft, MDX Health SA, Agilent Technologies Inc., Illumina Inc., Oxford Nanopore Technologies Ltd., Quantum Biosystems Inc., Menarini Silicon Biosystems Inc., Pathway Genomics Corporation, Sysmex Corporation, Janssen Global Services LLC, Natera Inc., ANGLE Plc, Bio Techne Corp, Biodesix Inc., CellMax Inc., CIRCULOGENE, Exact Sciences Corporation, Epic Sciences Inc., Exosome Diagnostics Inc., GRAIL Inc., Inivata Ltd., NIPD Genetics, Oncocyte Corporation, Personal Genome Diagnostics Inc., RainDance Technologies Inc., Thrive Earlier Detection Corp.

Global Liquid Biopsy Market Trends and Insights

Major companies operating in the liquid biopsy market are focusing on developing innovative solutions, such as comprehensive circulating tumor DNA (ctDNA) genomic-profiling assays, to accelerate noninvasive cancer profiling, enable faster therapeutic decision-making, and broaden access to precision oncology where tissue is limited or unobtainable. A ctDNA comprehensive genomic-profiling assay analyzes fragments of tumor-derived cell-free DNA circulating in blood to detect somatic small variants, copy-number changes, insertions/deletions, and immuno-oncology signatures (e.g., bTMB and bMSI), offering broader tumor insight without the invasiveness, sampling bias, and longer turnaround time of traditional tissue biopsies. For instance, in November 2023, Illumina Inc., a US–based sequencing and genomics company, launched TruSight Oncology 500 ctDNA v2, a research-use liquid biopsy panel for noninvasive genomic profiling of solid tumors, integrating an expanded hybrid-capture panel with DRAGEN bioinformatics for sequencing 523 biomarkers from low cfDNA input. The assay enriches and detects SVs, CNVs, indels, and immuno-oncology metrics with high analytical performance, offers streamlined workflows with a single hybridization step and <4-day turnaround, and is compatible with NovaSeq systems and upcoming automation. It supports use when tissue is unavailable or delayed, complements tissue testing, and enables broad pan-cancer research and trial screening, providing faster insights, suitability for low-input samples, and easier adoption across distributed lab environments.

Need data on a specific region in this market?

What Are Latest Mergers And Acquisitions In The Liquid Biopsy Market?

In February 2024, Veracyte Inc., a US-based diagnostics company, acquired C2i Genomics Inc. for $70 million. With this acquisition, Veracyte is planning to enhance its diagnostics platform with whole-genome minimal residual disease (MRD) capabilities. This acquisition allows Veracyte to utilize C2i's AI-driven technology for improved detection of circulating tumor DNA from blood samples, aiming to expand its cancer care offerings. C2i Genomics Inc. is a US-based company, providing AI-powered liquid biopsy for cancer diagnostics.

Regional Outlook

North America was the largest region in the liquid biopsy market in 2025. Western Europe was the second largest region in the liquid biopsy market. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Liquid Biopsy Market?

The liquid biopsy market includes revenues earned by entities by DNA collection tubes, tests, and reagents. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Liquid Biopsy Market Report 2026?

The liquid biopsy market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the liquid biopsy industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Liquid Biopsy Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $1.71 billion
Revenue Forecast In 2035 $3.11 billion
Growth Rate CAGR of 17.3% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Product, Clinical Application, End User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled QIAGEN NV, Roche Diagnostics Ltd., Bio-Rad Laboratories Inc., Myriad Genetics Inc., Guardant Health Inc., Thermo Fisher Scientific Inc., Biocept Inc., Trovagene Inc., Fraunhofer-Gesellschaft, MDX Health SA, Agilent Technologies Inc., Illumina Inc., Oxford Nanopore Technologies Ltd., Quantum Biosystems Inc., Menarini Silicon Biosystems Inc., Pathway Genomics Corporation, Sysmex Corporation, Janssen Global Services LLC, Natera Inc., ANGLE Plc, Bio Techne Corp, Biodesix Inc., CellMax Inc., CIRCULOGENE, Exact Sciences Corporation, Epic Sciences Inc., Exosome Diagnostics Inc., GRAIL Inc., Inivata Ltd., NIPD Genetics, Oncocyte Corporation, Personal Genome Diagnostics Inc., RainDance Technologies Inc., Thrive Earlier Detection Corp.
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Liquid Biopsy Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Liquid Biopsy Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Liquid Biopsy Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Liquid Biopsy Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Rising Adoption Of Non-Invasive Cancer Diagnostics

4.2.2 Increasing Use Of Liquid Biopsy For Early Cancer Detection

4.2.3 Growing Demand For Real-Time Treatment Monitoring

4.2.4 Expansion Of Liquid Biopsy In Personalized Oncology

4.2.5 Rising Clinical Acceptance As An Alternative To Tissue Biopsy

5. Liquid Biopsy Market Analysis Of End Use Industries

5.1 Reference Laboratories

5.2 Hospitals And Physician Laboratories

5.3 Academic And Research Centers

5.4 Cancer Diagnostic Centers

5.5 Biotechnology Companies

6. Liquid Biopsy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Liquid Biopsy Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Liquid Biopsy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Liquid Biopsy Market Size, Comparisons And Growth Rate Analysis

7.3. Global Liquid Biopsy Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Liquid Biopsy Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Liquid Biopsy Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Liquid Biopsy Market Segmentation

9.1. Global Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Assay Kits, Instruments, Services

9.2. Global Liquid Biopsy Market, Segmentation By Clinical Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Early Cancer Screening, Therapy Selection, Treatment Monitoring, Recurrence Monitoring

9.3. Global Liquid Biopsy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Reference Laboratories, Hospitals and Physician Laboratories, Academic and Research Centers

9.4. Global Liquid Biopsy Market, Sub-Segmentation Of Assay Kits, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

cfDNA Assays, ctDNA Assays, Exosome-based Assays, RNA-based Assays

9.5. Global Liquid Biopsy Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

PCR Instruments, Next-Generation Sequencing (NGS) Instruments, Microarray Instruments

9.6. Global Liquid Biopsy Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Testing Services, Data Analysis Services, Laboratory Services

10. Liquid Biopsy Market Regional And Country Analysis

10.1. Global Liquid Biopsy Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Liquid Biopsy Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Liquid Biopsy Market

11.1. Asia-Pacific Liquid Biopsy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Liquid Biopsy Market, Segmentation By Product, Segmentation By Clinical Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Liquid Biopsy Market

12.1. China Liquid Biopsy Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Liquid Biopsy Market, Segmentation By Product, Segmentation By Clinical Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Liquid Biopsy Market

13.1. India Liquid Biopsy Market, Segmentation By Product, Segmentation By Clinical Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Liquid Biopsy Market

14.1. Japan Liquid Biopsy Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Liquid Biopsy Market, Segmentation By Product, Segmentation By Clinical Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Liquid Biopsy Market

15.1. Australia Liquid Biopsy Market, Segmentation By Product, Segmentation By Clinical Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Liquid Biopsy Market

16.1. Indonesia Liquid Biopsy Market, Segmentation By Product, Segmentation By Clinical Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Liquid Biopsy Market

17.1. South Korea Liquid Biopsy Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Liquid Biopsy Market, Segmentation By Product, Segmentation By Clinical Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Liquid Biopsy Market

18.1. Taiwan Liquid Biopsy Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Liquid Biopsy Market, Segmentation By Product, Segmentation By Clinical Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Liquid Biopsy Market

19.1. South East Asia Liquid Biopsy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Liquid Biopsy Market, Segmentation By Product, Segmentation By Clinical Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Liquid Biopsy Market

20.1. Western Europe Liquid Biopsy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Liquid Biopsy Market, Segmentation By Product, Segmentation By Clinical Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Liquid Biopsy Market

21.1. UK Liquid Biopsy Market, Segmentation By Product, Segmentation By Clinical Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Liquid Biopsy Market

22.1. Germany Liquid Biopsy Market, Segmentation By Product, Segmentation By Clinical Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Liquid Biopsy Market

23.1. France Liquid Biopsy Market, Segmentation By Product, Segmentation By Clinical Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Liquid Biopsy Market

24.1. Italy Liquid Biopsy Market, Segmentation By Product, Segmentation By Clinical Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Liquid Biopsy Market

25.1. Spain Liquid Biopsy Market, Segmentation By Product, Segmentation By Clinical Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Liquid Biopsy Market

26.1. Eastern Europe Liquid Biopsy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Liquid Biopsy Market, Segmentation By Product, Segmentation By Clinical Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Liquid Biopsy Market

27.1. Russia Liquid Biopsy Market, Segmentation By Product, Segmentation By Clinical Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Liquid Biopsy Market

28.1. North America Liquid Biopsy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Liquid Biopsy Market, Segmentation By Product, Segmentation By Clinical Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Liquid Biopsy Market

29.1. USA Liquid Biopsy Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Liquid Biopsy Market, Segmentation By Product, Segmentation By Clinical Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Liquid Biopsy Market

30.1. Canada Liquid Biopsy Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Liquid Biopsy Market, Segmentation By Product, Segmentation By Clinical Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Liquid Biopsy Market

31.1. South America Liquid Biopsy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Liquid Biopsy Market, Segmentation By Product, Segmentation By Clinical Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Liquid Biopsy Market

32.1. Brazil Liquid Biopsy Market, Segmentation By Product, Segmentation By Clinical Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Liquid Biopsy Market

33.1. Middle East Liquid Biopsy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Liquid Biopsy Market, Segmentation By Product, Segmentation By Clinical Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Liquid Biopsy Market

34.1. Africa Liquid Biopsy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Liquid Biopsy Market, Segmentation By Product, Segmentation By Clinical Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Liquid Biopsy Market Regulatory and Investment Landscape

36. Liquid Biopsy Market Competitive Landscape And Company Profiles

36.1. Liquid Biopsy Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Liquid Biopsy Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Liquid Biopsy Market Company Profiles

36.3.1. QIAGEN NV Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Roche Diagnostics Ltd. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Bio-Rad Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Myriad Genetics Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Guardant Health Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Liquid Biopsy Market Other Major And Innovative Companies

Thermo Fisher Scientific Inc., Menarini Silicon Biosystems, Biocept Inc., Janssen Diagnostics LLC, Trovagene Inc., Fraunhofer-Gesellschaft, MDX Health SA, Agilent Technologies Inc., Illumina Inc., Oxford Nanopore Technologies Ltd., Quantum Biosystems Inc., Menarini Silicon Biosystems Inc., Pathway Genomics Corporation, Sysmex Corporation, Janssen Global Services LLC

38. Global Liquid Biopsy Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Liquid Biopsy Market

40. Liquid Biopsy Market High Potential Countries, Segments and Strategies

40.1 Liquid Biopsy Market In 2030 - Countries Offering Most New Opportunities

40.2 Liquid Biopsy Market In 2030 - Segments Offering Most New Opportunities

40.3 Liquid Biopsy Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Liquid Biopsy Market, Overview Of Key Products - Product Examples
  • Table 2: Global Liquid Biopsy Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Liquid Biopsy Market, Supply Chain Analysis
  • Table 4: Global Liquid Biopsy Market, Major Raw Material Providers
  • Table 5: Global Liquid Biopsy Market, Major Resource Providers
  • Table 6: Global Liquid Biopsy Market, Major Manufacturers (Suppliers)
  • Table 7: Global Liquid Biopsy Market, Major Distributors And Channel Partners
  • Table 8: Global Liquid Biopsy Market, Key Technologies & Future Trends
  • Table 9: Global Liquid Biopsy Market, Major Trends
  • Table 10: Global Liquid Biopsy Market, Major End Users
  • Table 11: Global Liquid Biopsy Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Liquid Biopsy Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Liquid Biopsy Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Liquid Biopsy Market - TAM, US$ Billion, 2025
  • Table 15: Global Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Liquid Biopsy Market, Segmentation By Clinical Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Liquid Biopsy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Liquid Biopsy Market, Sub-Segmentation Of Assay Kits, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Liquid Biopsy Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Liquid Biopsy Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Liquid Biopsy Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Liquid Biopsy Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Asia-Pacific, Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Asia-Pacific, Liquid Biopsy Market, Segmentation By Clinical Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Asia-Pacific, Liquid Biopsy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: China, Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: China, Liquid Biopsy Market, Segmentation By Clinical Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: China, Liquid Biopsy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: India, Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: India, Liquid Biopsy Market, Segmentation By Clinical Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: India, Liquid Biopsy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: Japan, Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: Japan, Liquid Biopsy Market, Segmentation By Clinical Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Japan, Liquid Biopsy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Australia, Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Australia, Liquid Biopsy Market, Segmentation By Clinical Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Australia, Liquid Biopsy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Indonesia, Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Indonesia, Liquid Biopsy Market, Segmentation By Clinical Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Indonesia, Liquid Biopsy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: South Korea, Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: South Korea, Liquid Biopsy Market, Segmentation By Clinical Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: South Korea, Liquid Biopsy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: Taiwan, Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: Taiwan, Liquid Biopsy Market, Segmentation By Clinical Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: Taiwan, Liquid Biopsy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: South East Asia, Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: South East Asia, Liquid Biopsy Market, Segmentation By Clinical Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: South East Asia, Liquid Biopsy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: Western Europe, Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: Western Europe, Liquid Biopsy Market, Segmentation By Clinical Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: Western Europe, Liquid Biopsy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: UK, Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: UK, Liquid Biopsy Market, Segmentation By Clinical Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: UK, Liquid Biopsy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: Germany, Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: Germany, Liquid Biopsy Market, Segmentation By Clinical Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: Germany, Liquid Biopsy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: France, Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: France, Liquid Biopsy Market, Segmentation By Clinical Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: France, Liquid Biopsy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: Italy, Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: Italy, Liquid Biopsy Market, Segmentation By Clinical Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Italy, Liquid Biopsy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Spain, Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Spain, Liquid Biopsy Market, Segmentation By Clinical Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Spain, Liquid Biopsy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Eastern Europe, Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Eastern Europe, Liquid Biopsy Market, Segmentation By Clinical Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Eastern Europe, Liquid Biopsy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Russia, Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Russia, Liquid Biopsy Market, Segmentation By Clinical Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Russia, Liquid Biopsy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: North America, Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: North America, Liquid Biopsy Market, Segmentation By Clinical Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: North America, Liquid Biopsy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: USA, Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: USA, Liquid Biopsy Market, Segmentation By Clinical Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: USA, Liquid Biopsy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: Canada, Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: Canada, Liquid Biopsy Market, Segmentation By Clinical Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: Canada, Liquid Biopsy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: South America, Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: South America, Liquid Biopsy Market, Segmentation By Clinical Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: South America, Liquid Biopsy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: Brazil, Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: Brazil, Liquid Biopsy Market, Segmentation By Clinical Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Brazil, Liquid Biopsy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Middle East, Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Middle East, Liquid Biopsy Market, Segmentation By Clinical Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Middle East, Liquid Biopsy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Africa, Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Africa, Liquid Biopsy Market, Segmentation By Clinical Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Africa, Liquid Biopsy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Global Liquid Biopsy Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 96: Global Liquid Biopsy Market - Company Scoring Matrix
  • Table 97: QIAGEN NV Financial Performance
  • Table 98: Roche Diagnostics Ltd. Financial Performance
  • Table 99: Bio-Rad Laboratories Inc. Financial Performance
  • Table 100: Myriad Genetics Inc. Financial Performance
  • Table 101: Guardant Health Inc. Financial Performance
  • Table 102: Global Liquid Biopsy Market, Competitive Benchmarking (In USD Billions)
  • Table 103: Global Liquid Biopsy Market, Competitive Dashboard
  • Table 104: Global Liquid Biopsy Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 105: Global, Liquid Biopsy Market Size Gain ($ Billion), Segmentation By Product, 2025 – 2030
  • Table 106: Global, Liquid Biopsy Market Size Gain ($ Billion), Segmentation By Clinical Application, 2025 – 2030
  • Table 107: Global, Liquid Biopsy Market Size Gain ($ Billion), Segmentation By End User, 2025 – 2030

List Of Figures

    Figure 1: Global Liquid Biopsy Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Liquid Biopsy Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Liquid Biopsy Market, Supply Chain Analysis
  • Figure 4: Global Liquid Biopsy Market, Major Raw Material Providers
  • Figure 5: Global Liquid Biopsy Market, Major Resource Providers
  • Figure 6: Global Liquid Biopsy Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Liquid Biopsy Market, Major Distributors And Channel Partners
  • Figure 8: Global Liquid Biopsy Market, Key Technologies & Future Trends
  • Figure 9: Global Liquid Biopsy Market, Major Trends
  • Figure 10: Global Liquid Biopsy Market, Major End Users
  • Figure 11: Global Liquid Biopsy Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Liquid Biopsy Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Liquid Biopsy Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Liquid Biopsy Market - TAM, US$ Billion, 2025
  • Figure 15: Global Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Liquid Biopsy Market, Segmentation By Clinical Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Liquid Biopsy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Liquid Biopsy Market, Sub-Segmentation Of Assay Kits, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Liquid Biopsy Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Liquid Biopsy Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Liquid Biopsy Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Liquid Biopsy Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Asia-Pacific, Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Asia-Pacific, Liquid Biopsy Market, Segmentation By Clinical Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Asia-Pacific, Liquid Biopsy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: China, Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: China, Liquid Biopsy Market, Segmentation By Clinical Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: China, Liquid Biopsy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: India, Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: India, Liquid Biopsy Market, Segmentation By Clinical Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: India, Liquid Biopsy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: Japan, Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: Japan, Liquid Biopsy Market, Segmentation By Clinical Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Japan, Liquid Biopsy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Australia, Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Australia, Liquid Biopsy Market, Segmentation By Clinical Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Australia, Liquid Biopsy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Indonesia, Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Indonesia, Liquid Biopsy Market, Segmentation By Clinical Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Indonesia, Liquid Biopsy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: South Korea, Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: South Korea, Liquid Biopsy Market, Segmentation By Clinical Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: South Korea, Liquid Biopsy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: Taiwan, Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: Taiwan, Liquid Biopsy Market, Segmentation By Clinical Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: Taiwan, Liquid Biopsy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: South East Asia, Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: South East Asia, Liquid Biopsy Market, Segmentation By Clinical Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: South East Asia, Liquid Biopsy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: Western Europe, Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: Western Europe, Liquid Biopsy Market, Segmentation By Clinical Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: Western Europe, Liquid Biopsy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: UK, Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: UK, Liquid Biopsy Market, Segmentation By Clinical Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: UK, Liquid Biopsy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: Germany, Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: Germany, Liquid Biopsy Market, Segmentation By Clinical Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: Germany, Liquid Biopsy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: France, Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: France, Liquid Biopsy Market, Segmentation By Clinical Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: France, Liquid Biopsy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: Italy, Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: Italy, Liquid Biopsy Market, Segmentation By Clinical Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Italy, Liquid Biopsy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Spain, Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Spain, Liquid Biopsy Market, Segmentation By Clinical Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Spain, Liquid Biopsy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Eastern Europe, Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Eastern Europe, Liquid Biopsy Market, Segmentation By Clinical Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Eastern Europe, Liquid Biopsy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Russia, Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Russia, Liquid Biopsy Market, Segmentation By Clinical Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Russia, Liquid Biopsy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: North America, Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: North America, Liquid Biopsy Market, Segmentation By Clinical Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: North America, Liquid Biopsy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: USA, Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: USA, Liquid Biopsy Market, Segmentation By Clinical Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: USA, Liquid Biopsy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: Canada, Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: Canada, Liquid Biopsy Market, Segmentation By Clinical Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: Canada, Liquid Biopsy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: South America, Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: South America, Liquid Biopsy Market, Segmentation By Clinical Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: South America, Liquid Biopsy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: Brazil, Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: Brazil, Liquid Biopsy Market, Segmentation By Clinical Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Brazil, Liquid Biopsy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Middle East, Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Middle East, Liquid Biopsy Market, Segmentation By Clinical Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Middle East, Liquid Biopsy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Africa, Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Africa, Liquid Biopsy Market, Segmentation By Clinical Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Africa, Liquid Biopsy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Global Liquid Biopsy Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 96: Global Liquid Biopsy Market - Company Scoring Matrix
  • Figure 97: QIAGEN NV Financial Performance
  • Figure 98: Roche Diagnostics Ltd. Financial Performance
  • Figure 99: Bio-Rad Laboratories Inc. Financial Performance
  • Figure 100: Myriad Genetics Inc. Financial Performance
  • Figure 101: Guardant Health Inc. Financial Performance
  • Figure 102: Global Liquid Biopsy Market, Competitive Benchmarking (In USD Billions)
  • Figure 103: Global Liquid Biopsy Market, Competitive Dashboard
  • Figure 104: Global Liquid Biopsy Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 105: Global, Liquid Biopsy Market Size Gain ($ Billion), Segmentation By Product, 2025 – 2030
  • Figure 106: Global, Liquid Biopsy Market Size Gain ($ Billion), Segmentation By Clinical Application, 2025 – 2030
  • Figure 107: Global, Liquid Biopsy Market Size Gain ($ Billion), Segmentation By End User, 2025 – 2030

Frequently Asked Questions

The Liquid Biopsy Market Report 2026 market was valued at $1.46 billion in 2025, increased to $1.71 billion in 2026, and is projected to reach $3.11 billion by 2030. request a sample here

The expected CAGR for the Liquid Biopsy Market Report 2026 market during the forecast period 2025–2030 is 16.2%. request a sample here

Major growth driver of the market includes: Government Funding Driving Growth In The Market For Cancer Detection in the Liquid Biopsy Market Report 2026 market. For further insights on this market, request a sample here

The liquid biopsy market covered in this report is segmented –
1) By Product: Assay Kits, Instruments, Services
2) By Clinical Application: Early Cancer Screening, Therapy Selection, Treatment Monitoring, Recurrence Monitoring
3) By End User: Reference Laboratories, Hospitals and Physician Laboratories, Academic and Research Centers Subsegments:
1) By Assay Kits: cfDNA Assays, ctDNA Assays, Exosome-based Assays, RNA-based Assays
2) By Instruments: PCR Instruments, Next-Generation Sequencing (NGS) Instruments, Microarray Instruments
3) By Services: Testing Services, Data Analysis Services, Laboratory Services
request a sample here

Major trend in this market includes: Advancements In Noninvasive Genomic Profiling For Solid Tumors Using Ctdna Assays For further insights on this market, request a sample here.

Major companies operating in the Liquid Biopsy Market Report 2026 market are Major companies operating in the liquid biopsy market are QIAGEN NV, Roche Diagnostics Ltd., Bio-Rad Laboratories Inc., Myriad Genetics Inc., Guardant Health Inc., Thermo Fisher Scientific Inc., Biocept Inc., Trovagene Inc., Fraunhofer-Gesellschaft, MDX Health SA, Agilent Technologies Inc., Illumina Inc., Oxford Nanopore Technologies Ltd., Quantum Biosystems Inc., Menarini Silicon Biosystems Inc., Pathway Genomics Corporation, Sysmex Corporation, Janssen Global Services LLC, Natera Inc., ANGLE Plc, Bio Techne Corp, Biodesix Inc., CellMax Inc., CIRCULOGENE, Exact Sciences Corporation, Epic Sciences Inc., Exosome Diagnostics Inc., GRAIL Inc., Inivata Ltd., NIPD Genetics, Oncocyte Corporation, Personal Genome Diagnostics Inc., RainDance Technologies Inc., Thrive Earlier Detection Corp. request a sample here.

North America was the largest region in the liquid biopsy market in 2025. Western Europe was the second largest region in the liquid biopsy market. The regions covered in the liquid biopsy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts